Bioxytran Inc (BIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,069 | -2,123 | -1,601 | -1,318 | -1,354 |
| Depreciation Amortization | 2 | 12 | 9 | 4 | 2 |
| Other Working Capital | 441 | 991 | 810 | 499 | 157 |
| Other Operating Activity | 1,388 | 594 | 493 | 566 | 1,028 |
| Operating Cash Flow | $-239 | $-527 | $-290 | $-248 | $-167 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | -9 | -23 | -17 | -15 | 0 |
| Other Investing Activity | -9 | -23 | -17 | -15 | 0 |
| Investing Cash Flow | $-9 | $-23 | $-17 | $-15 | $0 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -40 | 323 | 302 | 261 | 167 |
| Common Stock Issued | 241 | 439 | 13 | 0 | N/A |
| Other Financing Activity | 0 | 292 | 0 | 0 | 0 |
| Financing Cash Flow | $201 | $1,054 | $316 | $261 | $167 |
| Beginning Cash Position | 510 | 5 | 5 | 5 | 5 |
| End Cash Position | 463 | 510 | 15 | 3 | 4 |
| Net Cash Flow | $-47 | $505 | $9 | $-2 | $-1 |
| Free Cash Flow | |||||
| Operating Cash Flow | -239 | -527 | -290 | -248 | -167 |
| Free Cash Flow | -239 | -527 | -290 | -248 | -167 |